An abbreviated version of the Brain Care Score predicts risk for dementia, stroke, and late-life depression based on lifestyle factors alone.

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

Suzanna's Kitchen breaded chicken has been recalled after soy, a major allergen, was not identified on the packaging.

Baseline neuropsychiatric profiles in older adults stratify future cognitive decline, neuropathology, and risk for MCI or dementia.

New recommendations focused on psychological intervention may help manage or reduce the impact of functional seizures.

Children referred to a first seizure clinic often see a neurologist epilepsy specialist within 1 week for timely diagnosis ...

Among women with fibromyalgia, overactive bladder is prevalent and may often be associated with higher symptom severity and comorbidity.

From 2008 to 2020, the cost of US medical school attendance increased, with trainees increasingly relying on federal loans.

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Cognitive impairment is positively associated with neuropsychiatric symptoms in both individuals with Down syndrome and older adults without Down syndrome.

The FDA has granted Fast Track designation to ST-503 for the treatment of small fiber neuropathy, a chronic neuropathic pain disorder.

Tolebrutinib failed to meet the primary endpoint in the phase 3 PERSEUS study involving patients with primary progressive multiple sclerosis.